[Beta-receptor blockers in ischemic heart disease: the pathophysiological and clinical aspects].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003097:Collateral Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology*; D004341:Drug Evaluation; D005080:Exercise Test; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D009200:Myocardial Contraction / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D010919:Placebos; D011943:Receptors, Adrenergic, beta / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D010919:Placebos; D011943:Receptors, Adrenergic, beta
Beta-Rezeptorenblocker bei ischämischer Herzkrankheit--pathophysiologische und klinische Aspekte.